Detalhe da pesquisa
1.
Relationship Between Dissociation and Antidepressant Effects of Esketamine Nasal Spray in Patients With Treatment-Resistant Depression.
Int J Neuropsychopharmacol
; 25(4): 269-279, 2022 04 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-35022754
2.
Comparison of Long-Term Efficacy and Safety of Esketamine Nasal Spray Plus Oral Antidepressant in Younger Versus Older Patients With Treatment-Resistant Depression: Post-Hoc Analysis of SUSTAIN-2, a Long-Term Open-Label Phase 3 Safety and Efficacy Study.
Am J Geriatr Psychiatry
; 30(5): 541-556, 2022 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-34750057
3.
Efficacy and safety of esketamine nasal spray by sex in patients with treatment-resistant depression: findings from short-term randomized, controlled trials.
Arch Womens Ment Health
; 25(2): 313-326, 2022 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-34973081
4.
The effect of esketamine in patients with treatment-resistant depression with and without comorbid anxiety symptoms or disorder.
Depress Anxiety
; 38(11): 1120-1130, 2021 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-34293233
5.
Efficacy and Safety of Esketamine Nasal Spray Plus an Oral Antidepressant in Elderly Patients With Treatment-Resistant Depression-TRANSFORM-3.
Am J Geriatr Psychiatry
; 28(2): 121-141, 2020 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-31734084
6.
Efficacy and Safety of Fixed-Dose Esketamine Nasal Spray Combined With a New Oral Antidepressant in Treatment-Resistant Depression: Results of a Randomized, Double-Blind, Active-Controlled Study (TRANSFORM-1).
Int J Neuropsychopharmacol
; 22(10): 616-630, 2019 10 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31290965
7.
Comments to pharmacological and behavioral divergence of ketamine enantiomers by Jordi Bonaventura et al.
Mol Psychiatry
; 27(4): 1860-1862, 2022 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-35177823
8.
Comments to Drs. Gastaldon, Raschi, Kane, Barbui, and Schoretsanitis.
Psychother Psychosom
; 90(2): 138-139, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-33108791
9.
Metabolic and body mass parameters after treatment with JNJ-37822681, a novel fast-dissociating D2 receptor antagonist, vs olanzapine in patients with schizophrenia.
Ann Clin Psychiatry
; 25(3): 173-83, 2013 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-23926573
10.
Intranasal esketamine effectively treats treatment-resistant depression in adults regardless of baseline irritability.
J Affect Disord
; 321: 153-160, 2023 01 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-36273682
11.
Montgomery-Åsberg Depression Rating Scale factors in treatment-resistant depression at onset of treatment: Derivation, replication, and change over time during treatment with esketamine.
Int J Methods Psychiatr Res
; 31(4): e1927, 2022 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-35749277
12.
Longitudinal Course of Adverse Events With Esketamine Nasal Spray: A Post Hoc Analysis of Pooled Data From Phase 3 Trials in Patients With Treatment-Resistant Depression.
J Clin Psychiatry
; 83(6)2022 09 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-36149841
13.
The relationship between adverse events during selective serotonin reuptake inhibitor treatment for major depressive disorder and nonremission in the suicide assessment methodology study.
J Clin Psychopharmacol
; 31(1): 31-8, 2011 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-21192140
14.
Comments to Drs. Bahji, Vazquez, and Zarate.
J Affect Disord
; 283: 262-264, 2021 03 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-33571795
15.
Health-related quality of life in depression: a STAR*D report.
Ann Clin Psychiatry
; 22(1): 43-55, 2010 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-20196982
16.
Relapse prevention in treatment-resistant major depressive disorder with rapid-acting antidepressants.
Adv Pharmacol
; 89: 237-259, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-32616208
17.
Esketamine Nasal Spray Plus Oral Antidepressant in Patients With Treatment-Resistant Depression: Assessment of Long-Term Safety in a Phase 3, Open-Label Study (SUSTAIN-2).
J Clin Psychiatry
; 81(3)2020 04 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-32316080
18.
A computerized decision support system for depression in primary care.
Prim Care Companion J Clin Psychiatry
; 11(4): 140-6, 2009.
Artigo
em Inglês
| MEDLINE | ID: mdl-19750065
19.
Barriers to implementation of a computerized decision support system for depression: an observational report on lessons learned in "real world" clinical settings.
BMC Med Inform Decis Mak
; 9: 6, 2009 Jan 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-19159458
20.
Efficacy and Safety of Flexibly Dosed Esketamine Nasal Spray Combined With a Newly Initiated Oral Antidepressant in Treatment-Resistant Depression: A Randomized Double-Blind Active-Controlled Study.
Am J Psychiatry
; 176(6): 428-438, 2019 06 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31109201